Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BIORA THERAPEUTICS, INC. (PROG)
|
Add to portfolio |
|
|
|
| Price: |
$2.25
| | Metrics |
| OS: |
13.9
|
M
| |
|
|
| Market cap: |
$31.2
|
M
| |
|
|
|
Net debt:
|
$106
|
M
| |
|
|
|
EV:
|
$137
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 1.2 | 0.2 | 144.0 | 128.0 |
| Revenue growth | 669.8% | -99.9% | 12.5% | |
| Cost of goods sold | 0.0 | 0.0 | 100.5 | 92.1 |
| Gross profit | 1.2 | 0.2 | 43.5 | 35.9 |
| Gross margin | 100.0% | 100.0% | 30.2% | 28.1% |
| Sales and marketing | 4.8 | 5.9 | 58.9 | 50.2 |
| Research and development | | | 63.4 | 48.7 |
| General and administrative | | | 61.3 | 51.2 |
| EBITA | -118.0 | -166.8 | -139.2 | -116.6 |
| EBITA margin | -9462.1% | -102964.2% | -96.7% | -91.1% |
| Amortization of intangibles | 0.5 | 0.9 | 0.9 | |
| EBIT | -118.5 | -167.7 | -140.1 | -116.6 |
| EBIT margin | -9502.2% | -103519.8% | -97.3% | -91.1% |
| Pre-tax income | -178.6 | -142.6 | -148.7 | -123.9 |
| Income taxes | -0.1 | -37.5 | -0.7 | 5.3 |
| Tax rate | 0.1% | 26.3% | 0.5% | |
| Net income | -247.4 | -192.5 | -228.8 | -0.1 |
| Net margin | -19840.6% | -118844.4% | -158.9% | -0.1% |
| |
| Diluted EPS | ($1.86) | ($3.82) | ($46.87) | ($27.72) |
| Shares outstanding (diluted) | 96.2 | 27.5 | 4.9 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|